ConcertAI issued its first research award grants as part of its Engaging Research to Achieve Cancer Care Equality (ERACE) program, which aims to further research into racial and ethnic disparities in cancer care.
The awardees include Dr. Samuel Washington III of the University of California, San Francisco and Dr. Sarah Markt of Case Western Reserve University, both oncology researchers. Both will receive $50,000 for their respective research efforts.
Washington's studies will look at drivers of racial disparities in managing advanced prostate cancer, using real-world data from ConcertAI that is linked to state-level measures of socioeconomic factors and healthcare resources.
Markt's research will use ConcertAI's patient registry to determine factors that affect the racial and gender disparities present in bladder cancer diagnosis and treatment.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
